Partnered Content

Watch now as Adalvo CEO Anil Okay shares with Citeline his perspectives on the rapidly-growing European B2B’s recent acquisition by private equity firm EQT. Find out what it means for the business, and how it may reflect wider pharma trends, in this insightful video interview.

Neurodiversity in the workplace reflects varied cognitive profiles, including conditions like autism, ADHD, and dyslexia. Aspire Pharma outlines steps to support neurodivergent employees, such as flexible work, clear communication, training for manager, and employee-led groups that promote inclusion

With the upcoming patent expirations in oncology biologics, biosimilar developers must act quickly to capitalize on ADCs and BsAbs - discover why.

Learn more about the challenges faced by today’s drug developers and the critical factors to consider as sponsors navigate the supply chain, keep up with regulatory requirements, and ensure patient access. Discover more about the role of generics and how Aspire Pharma can help.

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Discover Henlius’ groundbreaking achievements, and their mission to deliver affordable, innovative drugs worldwide through strategic partnerships.